Although clinical trial data have quantified patient survival gains associated with tyrosine kinase inhibitors in chronic myeloid leukemia, the overall value of these benefits is unknown.
Wesley Yin, PhD
Advertisement
Articles by Wesley Yin, PhD
Advertisement
Latest Updated Articles
- Value of Survival Gains in Chronic Myeloid Leukemia
Published: November 30th 2012 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Imlunestrant for ER+ and HER2-Negative Breast Cancer
2
In Primary Care–Oncology Collaboration, the Baton Goes Both Ways
3
Marathon Health, Medbridge Partner to Launch Integrated Virtual MSK Care Program
4
Myasthenia Gravis–Induced Fears of Diagnosed Patients During the Pandemic
5
